RAPT

RAPT Therapeutics (RAPT)

About RAPT Therapeutics (RAPT)

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$1.22

Daily low

$1.14

Price at open

$1.20

52 Week High

$9.65

52 Week Low

$0.79

Market cap

150.5M

Dividend yield

0.00%

Volume

376,931

Avg. volume

467,211

P/E ratio

-.37

RAPT Therapeutics News